Venture Capital Funding Survey, First Quarter 2014 VENTURE CAPITAL FUNDING, FIRST QUARTER 2014 This is a listing of many of the Bay Area firms that received venture capital financing between Jan. 1 and March 31, 2014. Most of the data was compiled from a survey conducted by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association in conjunction with the Mercury News. In the case of some investments there may have been other participants in the round who are not credited. Also, the amounts listed may not include all venture funding the company received during the quarter. *Indicates this is a seed or first-round infusion of money from venture capitalists. These companies may have received money previously from other investors and aren't necessarily startups. BIOTECHNOLOGY / HEALTH Name City Stage Amount Investors Description 3-V Biosciences Menlo Park Early Stage $4,749,000 Kleiner Perkins Therapeutics that modulate Caufield & Byers, pathways for the treatment of New Enterprise oncology Associates Acerta Pharma San Carlos Startup/Seed $13,000,000 Frazier Healthcare, Treatments for cancer and undisclosed firm autoimmune diseases Afferent Pharmaceuticals San Mateo Early Stage $6,300,000 Domain Associates, Clinical-stage undisclosed firm biopharmaceutical company Altura Medical Menlo Park Expansion $4,000,000 SV Life Sciences Medical devices Advisers, undisclosed firm Atara Biotherapeutics Brisbane Early Stage $13,500,000 Amgen, Domain Drug development company Associates, Duff Ackerman & Goodrich, Kleiner Perkins Caufield & Byers, undisclosed firms Bell Biosystems Palo Alto Expansion $2,058,000 Undisclosed firm Stem-cell research technology tools BioTrace Medical* San Mateo Startup/Seed $3,500,000 Okapi Venture Health care industry Capital, undisclosed firm Cardiva Medical Sunnyvale Later Stage $3,300,000 PTV Sciences Medical device company Cerebrotech Medical Pleasanton Early Stage $2,000,000 TriStar Technology Technology for non-invasive Systems Ventures, monitoring of patients undisclosed firm Cerephex Los Gatos Early Stage $9,820,000 Undisclosed firm, Medical device company Versant Ventures CogENT Therapeutics* Hayward Early Stage $1,100,000 Band of Angels, Medical device company undisclosed firm Coherus Biosciences Redwood City Early Stage $5,225,000 Sofinnova Ventures Clinical-stage, biosimilar biologics company Page 1 of 25 Venture Capital Funding Survey, First Quarter 2014 CytomX Therapeutics South San Early Stage $4,400,000 Canaan Partners Proteolytically-activated Francisco antibodies Earlens* Redwood City Early Stage $36,258,000 Aisling Capital, New Medical device company Enterprise Associates, undisclosed firm Edison Pharmaceuticals Mountain View Later Stage $50,000,000 Undisclosed firm Treatment for children and adults with mitochondrial diseases Element Science* San Francisco Startup/Seed $12,500,100 Google Ventures, Devices for the treatment of Prospect Venture sudden cardiac death Partners, Third Rock Ventures Endogastric Solutions San Mateo Later Stage $358,000 Canaan Partners Surgery solutions for gastroesophageal reflux disease First Aid Shot Therapy Burlingame Expansion $7,048,100 Sofinnova Ventures, Consumer healthcare undisclosed firms company Hampton Creek Foods San Francisco Early Stage $22,999,900 Collaborative Fund, Development of plant-based Eagle Cliff Partners, egg ingredients Horizons Ventures, Khosla Ventures, undisclosed firms Igenica Burlingame Early Stage $7,034,000 5AM Venture Antibodies and ADCs for the Management, treatment of cancer Column Group, OrbiMed Advisors, Third Rock Ventures Intuity Medical Sunnyvale Later Stage $1,500,000 Accuitive Medical Therapeutic medical devices Ventures, Investor to monitor blood glucose Growth Capital, levels Thomas Mcnerney and Partners, U.S. Venture Partners, Venrock, Versant Ventures Invuity San Francisco Later Stage $22,384,200 HealthCare Royalty Visualization products for Partners, InterWest minimally invasive surgical Partners, Kleiner application Perkins Caufield & Byers, undisclosed firm, Valence Life Sciences, Windham Venture Partners Jaguar Animal Health* San Francisco Startup/Seed $2,000,000 Bioveda China Fund Health solutions to all animals K2 Therapeutics San Francisco Early Stage $500,000 5AM Venture Therapeutics for prevention Management or treatment of microbial infections KineMed Emeryville Later Stage $6,442,000 Undisclosed firm Biotech company Labrys Biologics Foster City Early Stage $8,206,000 Canaan Partners, Biotechnology company Sofinnova Ventures Page 2 of 25 Venture Capital Funding Survey, First Quarter 2014 Nanomix Emeryville Later Stage $12,000,000 Undisclosed firms Nanotechnology company NeoTract Pleasanton Later Stage $18,157,000 New Enterprise Medical devices that address Associates unmet needs in the field of urology NeuraLieve Sunnyvale Later Stage $2,212,000 Undisclosed firm Medical technology company Nina Biotherapeutics Brisbane Startup/Seed $878,000 Domain Associates, Therapies to combat Kleiner Perkins cachexia in cancer patients Caufield & Byers Oculeve South San Early Stage $16,650,000 Kleiner Perkins Treatment for dry eye Francisco Caufield & Byers, New Enterprise Associates, Versant Ventures Pinta Biotherapeutics Brisbane Early Stage $6,311,000 Domain Associates, Therapies to reverse protein Kleiner Perkins energy wasting in renal Caufield & Byers disease Powervision Belmont Later Stage $24,000,000 Advanced Developing an Technology Ventures, accommodating intraocular Frazier Healthcare, lens Johnson & Johnson Development, Lexington Partners, Medtronic, Venrock Providence Medical Lafayette Early Stage $6,800,100 Aphelion Capital, Medical device company Technology* Researchoration Technologies, Stanmore Medical Investments Pulmonx Redwood City Later Stage $9,999,900 Kaiser Permanente Medical devices for the Ventures, Kleiner treatment of pulmonary Perkins Caufield & disorders Byers, Montreux Equity Partners, undisclosed firm Rennovia Menlo Park Expansion $23,321,000 Undisclosed firm Chemicals from renewable feedstock Santa Maria Biotherapeutics Brisbane Early Stage $6,311,000 Domain Associates, Biotechnology company Kleiner Perkins Caufield & Byers SFJ Pharmaceuticals Pleasanton Expansion $450,000 Clarus Ventures, Specialty pharma company undisclosed firm Transcend Medical Menlo Park Later Stage $22,500,000 Canaan Partners, Medical devices HLM Venture Partners, Kaiser Permanente Ventures, undisclosed firm Page 3 of 25 Venture Capital Funding Survey, First Quarter 2014 Transcriptic Menlo Park Early Stage $2,800,000 AME Cloud Ventures, Androbotic laboratory Boost VC, Data infrastructure as a service Collective, Google Ventures, IA Ventures Twist Bioscience San Francisco Early Stage $6,923,000 Arch Venture Products and services Partners, Paladin Capital Management Versartis Redwood City Early Stage $10,000,000 Advent Venture Biotechnology company Partners, Aisling Capital, Index Ventures, New Leaf Venture Partners, Sofinnova Ventures, undisclosed firms Versartis Redwood City Early Stage $55,000,000 Advent Venture Biotechnology company Partners, Aisling Capital, Fidelity Investment Funds II, New Leaf Venture Partners, Sofinnova Ventures, undisclosed firm ZIPLINE MEDICAL Campbell Expansion $4,299,900 Claremont Creek Noninvasive surgical skin Ventures, RA Capital closure devices Management, X/Seed Capital Management BUSINESS SERVICES Name City Stage Amount Investors Description AdStage San Francisco Early Stage $1,000,000 Undisclosed firm Tools to help businesses advertise online AppDirect San Francisco Expansion $35,000,000 Foundry Group, Cloud service marketplace Mithril Capital company Management, StarVest Partners, undisclosed firm, iNovia Capital ARIA Retirement Solutions San Francisco Expansion $200,000 Polaris Partners OME solutions Chart.Io San Francisco Early Stage $2,151,000 Avalon Ventures GP Google analytics for business data Docker San Francisco Expansion $15,000,000 Benchmark Capital Multi-language application Management, platform Greylock Partners, Insight Venture Partners, Trinity Ventures, undisclosed firm Dropbox San Francisco Expansion $325,000,000 Sequoia Capital Online file storage and sharing services Page 4 of 25 Venture Capital Funding Survey, First Quarter 2014 Eventbrite San Francisco Later Stage $60,000,000 T. Rowe Price Online ticketing and event Threshold planning company Partnerships, Tiger Global Flite San Francisco Later Stage $9,000,000 General Catalyst Cloud-based advertising Partners, Sequoia platform Capital Glyde Palo Alto Later Stage $1,190,000 Charles River Online e-commerce platform Ventures, RPM for used goods Ventures Jivox Foster City Expansion $5,800,000 Helion Venture Interactive video advertising Partners, Opus technology company Capital, undisclosed firms KAIZEN Platform San Francisco Early Stage $5,000,000 Fidelity Ventures, User interface A/B testing Gree Ventures platform planbcd Leadspace Menlo Park Expansion $300,100 Battery Ventures Engaged in social lead targeting technology m>PATH* Palo Alto Early Stage $1,650,000 Jump Investors Mobile-app management software Omniata* San Francisco Early Stage $5,200,000 Creandum AB, Sigma Unified digital platform West Renewable Funding Oakland Expansion $1,975,000 NGEN Partners Financing solutions for renewable energy Stripe San Francisco Early Stage $80,000,000 Founders Fund, Platform that accepts General Catalyst payments online Partners, Khosla Ventures, Sequoia Capital Vaurum* Palo Alto Early Stage $990,000 Battery Ventures Builds high-performance exchange technology Vungle San Francisco